Dmitry Balyasny’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
Dmitry Balyasny's AXSM Position: Q3 2026 in Review
Dmitry Balyasny sold out of Axsome Therapeutics (AXSM) in Q3 2026, closing a stake of 76,250 shares — an estimated $18.7M sold.
Dmitry Balyasny first reported a position in AXSM in Q1 2018 and held it in 9 quarters. The position peaked at $18.7M in Q2 2026. 466 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- Dmitry Balyasny reported no remaining Axsome Therapeutics position as of Q3 2026 after selling out during the quarter.
- Dmitry Balyasny sold 76,250 Axsome Therapeutics shares in Q3 2026, an estimated $18.7M.
- Dmitry Balyasny first reported a position in Axsome Therapeutics in Q1 2018 and held it in 9 quarters.
- Dmitry Balyasny's Axsome Therapeutics position peaked at $18.7M in Q2 2026.
- 466 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.